Hadassah and Neurogenesis Announce Groundbreaking Results From Phase 2 MS Study
A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by…
